85
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis

, , , &
Received 06 Dec 2023, Accepted 24 Apr 2024, Published online: 24 May 2024

References

  • Abdullah KM, Udoh EA, Shewen PE, Mellors A. 1992. A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins. Infect Immun. 60(1):56–62. doi: 10.1128/iai.60.1.56-62.1992.
  • Akinosoglou K, Tsiakalos A, Dimopoulou ID, Schinas G, Polyzou E, Kourea-Kremastinou J, Pitiriga VC. 2024. Antimicrobial resistance rates of urogenital Mycoplasma hominis and Ureaplasma species before and during the COVID-19 pandemic: results from a Greek survey, 2014 to 2022. J Antibiot. 77(2):120–125. doi: 10.1038/s41429-023-00680-5.
  • Arfi Y, Minder L, Di Primo C, Le Roy A, Ebel C, Coquet L, Claverol S, Vashee S, Jores J, Blanchard A, et al. 2016. MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G. Proc Natl Acad Sci USA. 113(19):5406–5411. doi: 10.1073/pnas.1600546113.
  • Asif AA, Roy M, Ahmad S. 2020. Rare case of Ureaplasma parvum septic arthritis in an immunocompetent patient. BMJ Case Rep. 13(9):e236396. doi: 10.1136/bcr-2020-236396.
  • Bayraktar MR, Ozerol IH, Gucluer N, Celik O. 2010. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis. 14(2):e90–e95. doi: 10.1016/j.ijid.2009.03.020.
  • Bébéar CM, Renaudin H, Charron A, Clerc M, Pereyre S, Bébéar C. 2003. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob Agents Chemother. 47(10):3323–3325. doi: 10.1128/AAC.47.10.3323-3325.2003.
  • Bebear CM, Renaudin H, Charron A, Gruson D, Lefrancois M, Bebear C. 2000. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother. 44(9):2557–2560. doi: 10.1128/AAC.44.9.2557-2560.2000.
  • Beeton ML, Chalker VJ, Jones LC, Maxwell NC, Spiller OB. 2016. Antibiotic Resistance among clinical Ureaplasma isolates recovered from neonates in England and Wales between 2007 and 2013. Antimicrob Agents Chemother. 60(1):52–56. doi: 10.1128/AAC.00889-15.
  • Beeton ML, Chalker VJ, Kotecha S, Spiller OB. 2009. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. J Antimicrob Chemother. 64(3):529–538. doi: 10.1093/jac/dkp218.
  • Beeton ML, Chalker VJ, Maxwell NC, Kotecha S, Spiller OB. 2009. Concurrent titration and determination of antibiotic resistance in Ureaplasma species with identification of novel point mutations in genes associated with resistance. Antimicrob Agents Chemother. 53(5):2020–2027. doi: 10.1128/AAC.01349-08.
  • Beeton ML, Payne MS, Jones L. 2019. The role of Ureaplasma spp. in the development of nongonococcal urethritis and infertility among men. Clin Microbiol Rev. 32(4):e00137–18. doi: 10.1128/CMR.00137-18.
  • Beeton ML, Spiller OB. 2017. Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? J Antimicrob Chemother. 72(2):330–337. doi: 10.1093/jac/dkw425.
  • Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y. 2021. Antimicrobial peptides: an update on classifications and databases. Int J Mol Sci. 22(21):11691. doi: 10.3390/ijms222111691.
  • Black FT, Krogsgaard-Jensen A. 1974. Application of indirect immunofluorescence, indirect haemagglutination and polyacrylamide-gel electrophoresis to human T-mycoplasmas. Acta Pathol Microbiol Scand B Microbiol Immunol. 82(3):345–353. doi: 10.1111/j.1699-0463.1974.tb02336.x.
  • Black FT. 1973. Modifications of the growth inhibition test and its application to human T-mycoplasmas. Appl Microbiol. 25(4):528–533. doi: 10.1128/am.25.4.528-533.1973.
  • Blanchard A, Razin S, Kenny GE, Barile MF. 1988. Characteristics of Ureaplasma urealyticum urease. J Bacteriol. 170(6):2692–2697. doi: 10.1128/jb.170.6.2692-2697.1988.
  • Boujemaa S, Mlik B, Ben Allaya A, Mardassi H, Ben Abdelmoumen Mardassi B. 2020. Spread of multidrug resistance among Ureaplasma serovars, Tunisia. Antimicrob Resist Infect Control. 9(1):19. doi: 10.1186/s13756-020-0681-5.
  • Boyle EM, Burdine J, Bolman RM. 1993. Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation. J Heart Lung Transplant. 12:508–512.
  • Bradhurst P, El-Haddad C, Ng J, Urriola N. 2021. Ureaplasma urealyticum septic oligoarthritis in a patient with severe secondary hypogammaglobulinaemia. Med J Aust. 214(11):506–507.e1. doi: 10.5694/mja2.51107.
  • Brown JT, Roberts MC. 1987. Cloning and characterization of tetM gene from a Ureaplasma urealyticum strain. Antimicrob Agents Chemother. 31(11):1852–1854. doi: 10.1128/AAC.31.11.1852.
  • Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. 2000. Rab7: a key to lysosome biogenesis. Mol Biol Cell. 11(2):467–480. doi: 10.1091/mbc.11.2.467.
  • Busolo F, Zanchetta R, Bertoloni G. 1984. Mycoplasmic localization patterns on spermatozoa from infertile men. Fertil Steril. 42(3):412–417. doi: 10.1016/s0015-0282(16)48082-9.
  • Cheng X, Naessens A, Lauwers S. 1993. Identification and characterization of serotype 4-specific antigens of Ureaplasma urealyticum by use of monoclonal antibodies. Infect Immun. 61(5):2253–2256. doi: 10.1128/iai.61.5.2253-2256.1993.
  • Cheng X, Naessens A, Lauwers S. 1994. Identification of serotype 1-, 3-, and 6-specific antigens of Ureaplasma urealyticum by using monoclonal antibodies. J Clin Microbiol. 32(4):1060–1062. doi: 10.1128/jcm.32.4.1060-1062.1994.
  • Choi JB, Lee S-J, Lee M-K, Lee S-J, Park DC, Kim HY, Lee DS, Choe H-S. 2018. Prevalence and antimicrobial susceptibility of Ureaplasma spp. and Mycoplasma hominis in asymptomatic individuals in Korea. Microb Drug Resist. 24(9):1391–1396. doi: 10.1089/mdr.2017.0431.
  • Clyde WA. 1964. Mycoplasma species identification based upon growth inhibition by specific antisera. J Immunol. 92(6):958–965. doi: 10.4049/jimmunol.92.6.958.
  • Coqueret O. 2003. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13(2):65–70. doi: 10.1016/s0962-8924(02)00043-0.
  • Dai G, Li R, Chen H, Jiang C, You X, Wu Y. 2015. A ferritin-like protein with antioxidant activity in Ureaplasma urealyticum. BMC Microbiol. 15(1):145. doi: 10.1186/s12866-015-0485-6.
  • Dando SJ, Nitsos I, Kallapur SG, Newnham JP, Polglase GR, Pillow JJ, Jobe AH, Timms P, Knox CL. 2012. The role of the multiple banded antigen of Ureaplasma parvum in intra-amniotic infection: major virulence factor or decoy? PLOS One. 7(1):e29856. doi: 10.1371/journal.pone.0029856.
  • Dando SJ, Nitsos I, Polglase GR, Newnham JP, Jobe AH, Knox CL. 2014. Ureaplasma parvum undergoes selection in utero resulting in genetically diverse isolates colonizing the chorioamnion of fetal sheep. Biol Reprod. 90:27. doi: 10.1095/biolreprod.113.113456.
  • de Barbeyrac B, Dupon M, Rodriguez P, Renaudin H, Bébéar C. 1996. A Tn1545-like transposon carries the tet(M) gene in tetracycline resistant strains of Bacteroides ureolyticus as well as Ureaplasma urealyticum but not Neisseria gonorrhoeae. J Antimicrob Chemother. 37(2):223–232. doi: 10.1093/jac/37.2.223.
  • De Francesco MA, Caracciolo S, Bonfanti C, Manca N. 2013. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother. 19(4):621–627. doi: 10.1007/s10156-012-0527-z.
  • De Francesco MA, Negrini R, Pinsi G, Peroni L, Manca N. 2009. Detection of Ureaplasma biovars and polymerase chain reaction-based subtyping of Ureaplasma parvum in women with or without symptoms of genital infections. Eur J Clin Microbiol Infect Dis. 28(6):641–646. doi: 10.1007/s10096-008-0687-z.
  • De Silva NS, Quinn PA. 1986. Endogenous activity of phospholipases A and C in Ureaplasma urealyticum. J Clin Microbiol. 23(2):354–359. doi: 10.1128/jcm.23.2.354-359.1986.
  • De Silva NS, Quinn PA. 1991. Localization of endogenous activity of phospholipases A and C in Ureaplasma urealyticum. J Clin Microbiol. 29(7):1498–1503. doi: 10.1128/jcm.29.7.1498-1503.1991.
  • Dégrange S, Renaudin H, Charron A, Bébéar C, Bébéar CM. 2008. Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines. Antimicrob Agents Chemother. 52(2):742–744. doi: 10.1128/AAC.00960-07.
  • DeSilva NS, Quinn PA. 1999. Characterization of phospholipase A1, A2, C activity in Ureaplasma urealyticum membranes. Mol Cell Biochem. 201(1–2):159–167. doi: 10.1023/a:1007082507407.
  • Dhawan B, Malhotra N, Sreenivas V, Rawre J, Khanna N, Chaudhry R, Mittal S. 2012. Ureaplasma serovars & their antimicrobial susceptibility in patients of infertility & genital tract infections. Indian J Med Res. 136:991–996.
  • Diaz Pallares C, Griener T, Vaughan S. 2020. Ureaplasma urealyticum disseminated multifocal abscesses in an immunocompromised adult patient: a case report. BMC Infect Dis. 20(1):47. doi: 10.1186/s12879-020-4771-z.
  • D’Inzeo T, De Angelis G, Fiori B, Menchinelli G, Liotti FM, Morandotti GA, De Maio F, Nagel D, Antonaci M, Sanguinetti M, et al. 2017. Comparison of mycoplasma IES, mycofast revolution and mycoplasma IST2 to detect genital mycoplasmas in clinical samples. J Infect Dev Ctries. 11(1):98–101. doi: 10.3855/jidc.8039.
  • Dongya M, Wencheng X, Xiaobo M, Lu W. 2008. Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum. Microb Drug Resist. 14(3):183–186. doi: 10.1089/mdr.2008.0817.
  • Doroftei B, Ilie O-D, Armeanu T, Anton E, Scripcariu I, Maftei R. 2021. The prevalence of Ureaplasma urealyticum and Mycoplasma Hominis infections in infertile patients in the northeast region of Romania. Medicina. 57(3):211. doi: 10.3390/medicina57030211.
  • Douthwaite S, Hansen LH, Mauvais P. 2000. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol Microbiol. 36(1):183–193. doi: 10.1046/j.1365-2958.2000.01841.x.
  • Duffy L, Glass J, Hall G, Avery R, Rackley R, Peterson S, Waites K. 2006. Fluoroquinolone resistance in Ureaplasma parvum in the United States. J Clin Microbiol. 44(4):1590–1591. doi: 10.1128/JCM.44.4.1590-1591.2006.
  • Dumke R. 2021. Antimicrobial resistance in clinical isolates of Ureaplasma spp. from samples in Germany. Antimicrob Agents Chemother. 95(5):AAC.02342–20. doi: 10.1128/AAC.02342-20.
  • Echahidi F, Muyldermans G, Lauwers S, Naessens A. 2000. Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates. Clin Diagn Lab Immunol. 7(4):563–567. doi: 10.1128/CDLI.7.4.563-567.2000.
  • Echahidi F, Muyldermans G, Lauwers S, Naessens A. 2001. Development of an enzyme-linked immunosorbent assay for serotyping Ureaplasma urealyticum strains using monoclonal antibodies. Clin Diagn Lab Immunol. 8(1):52–57. doi: 10.1128/CDLI.8.1.52-57.2001.
  • Famuyide ME, Hasday JD, Carter HC, Chesko KL, He J-R, Viscardi RM. 2009. Surfactant protein-A limits Ureaplasma-mediated lung inflammation in a murine pneumonia model. Pediatr Res. 66(2):162–167. doi: 10.1203/PDR.0b013e3181aabd66.
  • Farkas B, Ostorházi E, Pónyai K, Tóth B, Adlan E, Párducz L, Marschalkó M, Kárpáti S, Rozgonyi F. 2011. Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals. Orv Hetil. 152(42):1698–1702. doi: 10.1556/OH.2011.29217.
  • Fernández J, Karau MJ, Cunningham SA, Greenwood-Quaintance KE, Patel R. 2016. Antimicrobial susceptibility and clonality of clinical Ureaplasma isolates in the United States. Antimicrob Agents Chemother. 60(8):4793–4798. doi: 10.1128/AAC.00671-16.
  • Fleming D, Cunningham SA, Patel R. 2022. Contribution of uremia to Ureaplasma-induced hyperammonemia. Microbiol Spectr. 10(1):e0194221. doi: 10.1128/spectrum.01942-21.
  • Fleming D, Karau M, Patel R. 2021. A novel bioreactor for the stable growth of Ureaplasma parvum and Ureaplasma urealyticum. J Microbiol Methods. 181:106131. doi: 10.1016/j.mimet.2020.106131.
  • Fleming D, Patel R. 2022. Flurofamide prevention and treatment of Ureaplasma-induced hyperammonemia. Microbiol Spectr. 10(5):e0192722. doi: 10.1128/spectrum.01927-22.
  • Ford DK, Smith JR. 1974. Non-specific urethritis associated with a tetracycline-resistant T-mycoplasma. Br J Vener Dis. 50(5):373–374. doi: 10.1136/sti.50.5.373.
  • Ford DK. 1967. Relationships between mycoplasma and the etiology of nongonococcal urethritis and Reiter’s syndrome. Ann N Y Acad Sci. 143(1):501–504. doi: 10.1111/j.1749-6632.1967.tb27694.x.
  • Furfaro LL, Spiller OB, Keelan JA, Payne MS. 2015. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin. Int J Antimicrob Agents. 46(3):319–324. doi: 10.1016/j.ijantimicag.2015.04.015.
  • Fuwa K, Seki M, Hirata Y, Yanagihara I, Nakura Y, Takano C, Kuroda K, Hayakawa S. 2018. Rapid and simple detection of Ureaplasma species from vaginal swab samples using a loop-mediated isothermal amplification method. Am J Reprod Immunol. 79(1):e12771. doi: 10.1111/aji.12771.
  • García-Castillo M, Morosini M-I, Gálvez M, Baquero F, del Campo R, Meseguer M-A. 2008. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates. J Antimicrob Chemother. 62(5):1027–1030. doi: 10.1093/jac/dkn337.
  • García-de-la-Fuente C, Miñambres E, Ugalde E, Sáez A, Martinez-Martinez L, Fariñas MC. 2008. Post-operative mediastinitis, pleuritis and pericarditis due to Mycoplasma hominis and Ureaplasma urealyticum with a fatal outcome. J Med Microbiol. 57(Pt 5):656–657. doi: 10.1099/jmm.0.47632-0.
  • Gay K, Stephens DS. 2001. Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J Infect Dis. 184(1):56–65. doi: 10.1086/321001.
  • Geers TA, Taege AJ, Longworth DL, Adal KA. 1999. Ureaplasma urealyticum: unusual cause of culture-negative mediastinitis. Clin Infect Dis. 29(4):949–950. doi: 10.1086/520476.
  • Geissdörfer W, Sandner G, John S, Gessner A, Schoerner C, Schröppel K. 2008. Ureaplasma urealyticum meningitis in an adult patient. J Clin Microbiol. 46(3):1141–1143. doi: 10.1128/JCM.01628-07.
  • Gerber L, Gaspert A, Braghetti A, Zwahlen H, Wüthrich R, Zbinden R, Mueller N, Fehr T. 2018. Ureaplasma and Mycoplasma in kidney allograft recipients-A case series and review of the literature. Transpl Infect Dis. 20:e12937. doi: 10.1111/tid.12937.
  • Ghorbanzadeh N, Peymani A, Ahmadpour-Yazdi H. 2020. Colorimetric-based detection of Ureaplasma urealyticum using gold nanoparticles. IET Nanobiotechnol. 14(1):19–24. doi: 10.1049/iet-nbt.2019.0088.
  • Glaser K, Silwedel C, Fehrholz M, Henrich B, Waaga-Gasser AM, Claus H, Speer CP. 2018. Ureaplasma isolates stimulate pro-inflammatory CC chemokines and matrix metalloproteinase-9 in neonatal and adult monocytes. PLOS One. 13(3):e0194514. doi: 10.1371/journal.pone.0194514.
  • Glaser K, Silwedel C, Fehrholz M, Waaga-Gasser AM, Henrich B, Claus H, Speer CP. 2017. Ureaplasma species differentially modulate pro- and anti-inflammatory cytokine responses in newborn and adult human monocytes pushing the state toward pro-inflammation. Front Cell Infect Microbiol. 7:484. doi: 10.3389/fcimb.2017.00484.
  • Glaser K, Silwedel C, Waaga-Gasser AM, Henrich B, Fehrholz M, Claus H, Speer CP. 2018. Ureaplasma isolates differentially modulate growth factors and cell adhesion molecules in human neonatal and adult monocytes. Cytokine. 105:45–48. doi: 10.1016/j.cyto.2018.01.026.
  • Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, Cassell GH. 2000. The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature. 407(6805):757–762. doi: 10.1038/35037619.
  • Goebel W, Chakraborty T, Kreft J. 1988. Bacterial hemolysins as virulence factors. Antonie Van Leeuwenhoek. 54(5):453–463. doi: 10.1007/BF00461864.
  • Gu X, Liu S, Guo X, Weng R, Zhong Z. 2020. Epidemiological investigation and antimicrobial susceptibility analysis of mycoplasma in patients with genital manifestations. J Clin Lab Anal. 34(4):e23118. doi: 10.1002/jcla.23118.
  • Harada K, Tanaka H, Komori S, Tsuji Y, Nagata K, Tsutsui H, Koyama K. 2008. Vaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses. Microbiol Immunol. 52(6):297–304. doi: 10.1111/j.1348-0421.2008.00039.x.
  • Harasawa R, Kanamoto Y. 1999. Differentiation of two biovars of Ureaplasma urealyticum based on the 16S-23S rRNA intergenic spacer region. J Clin Microbiol. 37(12):4135–4138. doi: 10.1128/JCM.37.12.4135-4138.1999.
  • Huang C, Long X, Jing S, Fan L, Xu K, Wang S, Zhu W. 2016. Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China. World J Urol. 34(7):1039–1044. doi: 10.1007/s00345-015-1724-z.
  • Huang X, Qiao Y, Zhou Y, Ruan Z, Kong Y, Li G, Xie X, Zhang J. 2018. Ureaplasma spp. lipid-associated membrane proteins induce human monocyte U937 cell cycle arrest through p53-independent p21 pathway. Int J Med Microbiol. 308(7):819–828. doi: 10.1016/j.ijmm.2018.07.005.
  • Inatomi T, Oue S, Ogihara T, Hira S, Hasegawa M, Yamaoka S, Yasui M, Tamai H. 2012. Antenatal exposure to Ureaplasma species exacerbates bronchopulmonary dysplasia synergistically with subsequent prolonged mechanical ventilation in preterm infants. Pediatr Res. 71(3):267–273. doi: 10.1038/pr.2011.47.
  • Ito K, Akai K, Nishiumi F, Nakura Y, Ning Wu H, Kurata T, Onodera A, Kawai Y, Kajiyama S, Yanagihara I. 2021. Ability of Ureaplasma parvum to invade mouse sperm, fertilize eggs through infected sperm, and impair mouse sperm function and embryo development. F S Sci. 2(1):13–23. doi: 10.1016/j.xfss.2020.12.003.
  • Jorgensen JH, Carroll KC, Funke G, Pfaller MA, Landry ML, Richter SS, Warnock DW, editors. 2011. Manual of clinical microbiology. 10th edition. Washington, D.C.: ASM Press.
  • Janczarek M, Vinardell J-M, Lipa P, Karaś M. 2018. Hanks-type serine/threonine protein kinases and phosphatases in bacteria: roles in signaling and adaptation to various environments. Int J Mol Sci. 19(10):2872. doi: 10.3390/ijms19102872.
  • Jänsch HH. 1972. Pathogenicity demonstration for urea splitting Mycoplasma in the human urogenital tract using a self-administered test. Hautarzt. 23(12):558.
  • Jiang P, Mellors A. 2013. O-Sialoglycoprotein endopeptidase. Guelph, ON N1G 2W1, Canada: Department of Chemistry and Biochemistry, University of Guelph, Uelph Waterloo Center for Graduate Work in Chemistry, Elsevier Science Bv.
  • Jin H, Qi C, Zou Y, Kong Y, Ruan Z, Ding H, Xie X, Zhang J. 2017. Biochanin A partially restores the activity of ofloxacin and ciprofloxacin against topoisomerase IV mutation-associated fluoroquinolone-resistant Ureaplasma species. J Med Microbiol. 66(11):1545–1553. doi: 10.1099/jmm.0.000598.
  • Kacerovsky M, Celec P, Vlkova B, Skogstrand K, Hougaard DM, Cobo T, Jacobsson B. 2013. Amniotic fluid protein profiles of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria. PLOS One. 8(3):e60399. doi: 10.1371/journal.pone.0060399.
  • Kamiya Y, Shimada Y, Ito S, Kikuchi M, Yasuda M, Kawamura Y, Deguchi T. 2013. Analysis of the quinolone-resistance determining region of the gyrA gene and the analogous region of the parC gene in Ureaplasma parvum and Ureaplasma urealyticum detected in first-void urine of men with non-gonococcal urethritis. J Antimicrob Chemother. 68(2):480–482. doi: 10.1093/jac/dks417.
  • Karim S, Bouchikhi C, Banani A, Fatemi HEL, Souho T, Erraghay S, Bennani B. 2020. Detection of Ureaplasma Biovars and subtyping of Ureaplasma parvum among women referring to a university hospital in Morocco. Infect Dis Obstet Gynecol. 2020:7286820–7286829. doi: 10.1155/2020/7286820.
  • Karou SD, Djigma F, Sagna T, Nadembega C, Zeba M, Kabre A, Anani K, Ouermi D, Gnoula C, Pietra V, et al. 2012. Antimicrobial resistance of abnormal vaginal discharges microorganisms in Ouagadougou, Burkina Faso. Asian Pac J Trop Biomed. 2(4):294–297. doi: 10.1016/S2221-1691(12)60025-2.
  • Kasprzykowska U, Sobieszczańska B, Duda-Madej A, Secewicz A, Nowicka J, Gościniak G. 2018. A twelve-year retrospective analysis of prevalence and antimicrobial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of Lower Silesia in Poland. Eur J Obstet Gynecol Reprod Biol. 220:44–49. doi: 10.1016/j.ejogrb.2017.11.010.
  • Kawai Y, Nakura Y, Wakimoto T, Nomiyama M, Tokuda T, Takayanagi T, Shiraishi J, Wasada K, Kitajima H, Fujita T, et al. 2015. In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan. Antimicrob Agents Chemother. 59(4):2358–2364. doi: 10.1128/AAC.04262-14.
  • Kechagia N, Bersimis S, Chatzipanagiotou S. 2008. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J Antimicrob Chemother. 62(1):122–125. doi: 10.1093/jac/dkn158.
  • Kenny GE, Cartwright FD. 1977. Effect of urea concentration on growth of Ureaplasma urealyticum (T-strain mycoplasma. J Bacteriol. 132(1):144–150.) doi: 10.1128/jb.132.1.144-150.1977.
  • Kilian M, Brown M, Brown T, Freundt E, Cassell G. 1984. Immunoglobulin Al protease activity in strains of Ureaplasma-urealyticum. Acta Pathol Microbiol Immunol Scand B. 92(1):61–64. doi: 10.1111/j.1699-0463.1984.tb02794.x.
  • Kilian M, Freundt E. 1984. Exclusive occurrence of an extracellular protease capable of cleaving the hinge region of human immunoglobulin-Al in strains of Ureaplasma-urealyticum. Isr J Med Sci. 20:938–941.
  • Kim JJ, Quinn PA, Fortier MA. 1994. Ureaplasma diversum infection in vitro alters prostaglandin E2 and prostaglandin F2a production by bovine endometrial cells without affecting cell viability. Infect Immun. 62(5):1528–1533. doi: 10.1128/iai.62.5.1528-1533.1994.
  • Knox CL, Allan JA, Allan JM, Edirisinghe WR, Stenzel D, Lawrence FA, Purdie DM, Timms P. 2003. Ureaplasma parvum and Ureaplasma urealyticum are detected in semen after washing before assisted reproductive technology procedures. Fertil Steril. 80(4):921–929. doi: 10.1016/s0015-0282(03)01125-7.
  • Knox CL, Dando SJ, Nitsos I, Kallapur SG, Jobe AH, Payton D, Moss TJM, Newnham JP. 2010. The severity of chorioamnionitis in pregnant sheep is associated with in vivo variation of the surface-exposed multiple-banded antigen/gene of Ureaplasma parvum. Biol Reprod. 83(3):415–426. doi: 10.1095/biolreprod.109.083121.
  • Kong F, Ma Z, James G, Gordon S, Gilbert GL. 2000. Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol. 38(3):1175–1179. doi: 10.1128/JCM.38.3.1175-1179.2000.
  • Kong Y, Li C, Li G, Yang T, Draz MS, Xie X, Zhang J, Ruan Z. 2022. In vitro activity of delafloxacin and finafloxacin against Mycoplasma hominis and Ureaplasma Species. Microbiol Spectr. 10(3):e0009922. doi: 10.1128/spectrum.00099-22.
  • Kotrotsiou T, Exindari M, Diza E, Gioula G, Melidou A, Kaplanis K, Malisiovas N. 2013. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum in asymptomatic women in Northern Greece. Hippokratia. 17:319–321.
  • Kotrotsiou T, Tzimoula K, Exindari M, Maria E, Diza E, Eudoxia D, Gioula G, Georgia G, Melidou A, Angeliki M, et al. 2015. Detection of the tetM resistance determinant among phenotypically sensitive Ureaplasma species by a novel real-time PCR method. Diagn Microbiol Infect Dis. 81(2):85–88. doi: 10.1016/j.diagmicrobio.2014.10.013.
  • Krausse R, Schubert S. 2010. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 16(11):1649–1655. doi: 10.1111/j.1469-0691.2009.03155.x.
  • Lee JY, Yang JS. 2020. Prevalence and antimicrobial susceptibility of Mycoplasma hominis and Ureaplasma species in nonpregnant female patients in South Korea indicate an increasing trend of pristinamycin-resistant isolates. Antimicrob Agents Chemother. 64(10):e01065-20. doi: 10.1128/AAC.01065-20.
  • Lendamba RW, Mbeang Nguema PP, Onanga R, Mombo L-E. 2022. Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon. Microb Pathog. 166:105528. doi: 10.1016/j.micpath.2022.105528.
  • Li C, Ren N, Wen X, Zhou P, Huang X, Gong R, Lv Y, Feng L, Wu H, Liu Z, et al. 2013. Changes in antimicrobial use prevalence in China: results from five point prevalence studies. PLOS One. 8(12):e82785. doi: 10.1371/journal.pone.0082785.
  • Lin JS, Kass EH. 1980. Fourteen serotypes of Ureaplasma urealyticum (T-mycoplasmas) demonstrated by the complement-dependent mycoplasmacidal test. Infection. 8(4):152–155. doi: 10.1007/BF01639122.
  • Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. 1999. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among Staphylococci. Antimicrob Agents Chemother. 43(5):1062–1066. doi: 10.1128/AAC.43.5.1062.
  • Lu C, Lu Ye T, Xing Zhu G, Ying Feng P, Ma H, Biao Lu R, Lai W. 2010. Phenotypic and genetic characteristics of macrolide and lincosamide resistant Ureaplasma urealyticum isolated in Guangzhou, China. Curr Microbiol. 61(1):44–49. doi: 10.1007/s00284-009-9574-9.
  • Luo R, Xun K, Zuo L, Sha F, Chen Y, Yu N, Jin D, Xie Y, He M, Liu F. 2022. Prevalence and antimicrobial resistance of Ureaplasma urealyticum and Mycoplasma hominis in patients with genital tract infection in Jiangsu, China. Clin Lab. 68(6):1151–1158. doi: 10.7754/Clin.Lab.2021.210706.
  • Ma H, Zhang X, Shi X, Zhang J, Zhou Y. 2021. Phenotypic antimicrobial susceptibility and genotypic characterization of clinical Ureaplasma isolates circulating in Shanghai, China. Front Microbiol. 12:724935. doi: 10.3389/fmicb.2021.724935.
  • Mahlouly J, Lhopitallier L, Suttels V, Mueller L, Wernly D, Borens O, Steinmetz S. 2020. Septic arthritis of the shoulder due to Ureaplasma urealyticum after emergency caesarean section: a case report. BMC Infect Dis. 20(1):767. doi: 10.1186/s12879-020-05497-3.
  • Mansour W. 2018. Tunisian antibiotic resistance problems: three contexts but one health. Afr Health Sci. 18(4):1202–1203. doi: 10.4314/ahs.v18i4.41.
  • Maraki S, Mavromanolaki VE, Nioti E, Stafylaki D, Minadakis G. 2018. Prevalence and antimicrobial susceptibility of Ureaplasma species and Mycoplasma hominis in Greek female outpatients, 2012–2016. J Chemother. 30(3):140–144. doi: 10.1080/1120009X.2017.1404287.
  • Marques LM, Rezende IS, Barbosa MS, Guimarães AMS, Martins HB, Campos GB, do Nascimento NC, Dos Santos AP, Amorim AT, Santos VM, et al. 2016. Ureaplasma diversum genome provides new insights about the interaction of the surface molecules of this Bacterium with the host. PLOS One. 11(9):e0161926. doi: 10.1371/journal.pone.0161926.
  • Martin P, Trieu-Cuot P, Courvalin P. 1986. Nucleotide sequence of the tetM tetracycline resistance determinant of the Streptococcal conjugative shuttle transposon Tn1545. Nucleic Acids Res. 14(17):7047–7058. doi: 10.1093/nar/14.17.7047.
  • Martinez MA, Das K, Saikolappan S, Materon LA, Dhandayuthapani S. 2013. A serine/threonine phosphatase encoded by MG_207 of Mycoplasma genitalium is critical for its virulence. BMC Microbiol. 13(1):44. doi: 10.1186/1471-2180-13-44.
  • Meygret A, Le Roy C, Renaudin H, Bébéar C, Pereyre S. 2018. Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015. J Antimicrob Chemother. 73(10):2696–2703. doi: 10.1093/jac/dky238.
  • Mihai M, Valentin N, Bogdan D, Carmen CM, Coralia B, Demetra S. 2011. Antibiotic susceptibility profiles of Mycoplasma hominis and Ureaplasma urealyticum isolated during a population-based study concerning women infertility in northeast Romania. Braz J Microbiol. 42(1):256–260. doi: 10.1590/S1517-83822011000100032.
  • Monecke S, Helbig JH, Jacobs E. 2003. Phase variation of the multiple banded protein in Ureaplasma urealyticum and Ureaplasma parvum. Int J Med Microbiol. 293(2–3):203–211. doi: 10.1078/1438-4221-00239.
  • Moser SA, Mayfield CA, Duffy LB, Waites KB. 2006. Genotypic characterization of Ureaplasma species by pulsed field gel electrophoresis. J Microbiol Methods. 67(3):606–610. doi: 10.1016/j.mimet.2006.05.012.
  • Murdoch CC, Skaar EP. 2022. Nutritional immunity: the battle for nutrient metals at the host-pathogen interface. Nat Rev Microbiol. 20(11):657–670. doi: 10.1038/s41579-022-00745-6.
  • Naessens A, Cheng X, Lauwers S, Robertson JA. 1998. Development of a monoclonal antibody to an Ureaplasma urealyticum serotype 9 antigen. J Clin Microbiol. 36(4):1125–1127. doi: 10.1128/JCM.36.4.1125-1127.1998.
  • Neyrolles O, Ferris S, Behbahani N, Montagnier L, Blanchard A. 1996. Organization of Ureaplasma urealyticum urease gene cluster and expression in a suppressor strain of Escherichia coli. J Bacteriol. 178(3):647–655. doi: 10.1128/jb.178.3.647-655.1996.
  • Neyrolles O, Wolschendorf F, Mitra A, Niederweis M. 2015. Mycobacteria, metals, and the macrophage. Immunol Rev. 264(1):249–263. doi: 10.1111/imr.12265.
  • Ngoo A, Eisemann J, Matsika A, Winkle D. 2020. Ureaplasma urealyticum infection presenting as pyelonephritis and perinephric abscess in an immunocompromised patient. BMJ Case Rep. 13(5):e234538. doi: 10.1136/bcr-2020-234538.
  • Nishiumi F, Kawai Y, Nakura Y, Yoshimura M, Wu HN, Hamaguchi M, Kakizawa S, Suzuki Y, Glass JI, Yanagihara I. 2021. Blockade of endoplasmic reticulum stress-induced cell death by Ureaplasma parvum vacuolating factor. Cell Microbiol. 23(12):e13392. doi: 10.1111/cmi.13392.
  • Nishiumi F, Ogawa M, Nakura Y, Hamada Y, Nakayama M, Mitobe J, Hiraide A, Sakai N, Takeuchi M, Yoshimori T, et al. 2017. Intracellular fate of Ureaplasma parvum entrapped by host cellular autophagy. Microbiologyopen. 6(3):e00441. doi: 10.1002/mbo3.441.
  • Njunda AL, Nsagha DS, Assob JCN, Palle JN, Kamga HL, Nde PF, Ntube MNC, Weledji PE. 2011. Genital mycoplasmas in women attending the Yaoundé University Teaching Hospital in Cameroon. J Public Health Afr. 2:e16. doi: 10.4081/jphia.2011.e16.
  • Nottelet P, Bataille L, Gourgues G, Anger R, Lartigue C, Sirand-Pugnet P, Marza E, Fronzes R, Arfi Y. 2021. The mycoplasma surface proteins MIB and MIP promote the dissociation of the antibody-antigen interaction. Sci Adv. 7(10):eabf2403. doi: 10.1126/sciadv.abf2403.
  • Novy MJ, Duffy L, Axthelm MK, Sadowsky DW, Witkin SS, Gravett MG, Cassell GH, Waites KB. 2009. Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci. 16(1):56–70. doi: 10.1177/1933719108325508.
  • Núñez-Calonge R, Caballero P, Redondo C, Baquero F, Martínez-Ferrer M, Meseguer MA. 1998. Ureaplasma urealyticum reduces motility and induces membrane alterations in human spermatozoa. Hum Reprod. 13(1O):2756–2761. doi: 10.1093/humrep/13.10.2756.
  • Ozdemır R, Sarı FN, Tunay ZO, Erdeve O, Canpolat FE, Oguz SS, Uras N, Dılmen U. 2012. The association between respiratory tract Ureaplasma urealyticum colonization and severe retinopathy of prematurity in preterm infants ≤1250 g. Eye. 26(7):992–996. doi: 10.1038/eye.2012.77.
  • Pailhoriès H, Chenouard R, Eveillard M, Kempf M, Pereyre S, Bébéar C, Lemarié C. 2019. A case of Ureaplasma parvum meningitis in an adult after transphenoidal ablation of craniopharyngioma. Int J Infect Dis. 84:5–7. doi: 10.1016/j.ijid.2019.04.024.
  • Palù G, Valisena S, Barile MF, Meloni GA. 1989. Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains. Eur J Epidemiol. 5(2):146–153. doi: 10.1007/BF00156820.
  • Pandelidis K, McCarthy A, Chesko KL, Viscardi RM. 2013. Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates. Pediatr Infect Dis J. 32(4):394–398. doi: 10.1097/INF.0b013e3182791ae0.
  • Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Methé BA, Inman J, Yooseph S, Xiao L, Cassell GH, et al. 2012. Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvumstrains. BMC Microbiol. 12(1):88. doi: 10.1186/1471-2180-12-88.
  • Park D-W, Bae Y-S, Nam J-O, Kim J-H, Lee Y-G, Park Y-K, Ryu SH, Baek S-H. 2002. Regulation of cyclooxygenase-2 expression by phospholipase D in human amnion-derived WISH cells. Mol Pharmacol. 61(3):614–619. doi: 10.1124/mol.61.3.614.
  • Pavlidis I, Spiller OB, Sammut Demarco G, MacPherson H, Howie SEM, Norman JE, Stock SJ. 2020. Cervical epithelial damage promotes Ureaplasma parvum ascending infection, intrauterine inflammation and preterm birth induction in mice. Nat Commun. 11(1):199. doi: 10.1038/s41467-019-14089-y.
  • Payne MS, Ireland DJ, Watts R, Nathan EA, Furfaro LL, Kemp MW, Keelan JA, Newnham JP. 2016. Ureaplasma parvum genotype, combined vaginal colonisation with Candida albicans, and spontaneous preterm birth in an Australian cohort of pregnant women. BMC Preg Childbirth. 16(1):312. doi: 10.1186/s12884-016-1110-x.
  • Pereyre S, Métifiot M, Cazanave C, Renaudin H, Charron A, Bébéar C, Bébéar CM. 2007. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics. Int J Antimicrob Agents. 29(2):207–211. doi: 10.1016/j.ijantimicag.2006.09.008.
  • Pereyre S, Tardy F, Renaudin H, Cauvin E, Del Prá Netto Machado L, Tricot A, Benoit F, Treilles M, Bébéar C. 2013. Identification and subtyping of clinically relevant human and ruminant mycoplasmas by use of matrix-assisted laser desorption ionization-time of flight mass spectro­metry. J Clin Microbiol. 51(10):3314–3323. doi: 10.1128/JCM.01573-13.
  • Piccinelli G, Gargiulo F, Biscaro V, Caccuri F, Caruso A, De Francesco MA. 2017. Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones. Infect Genet Evol. 47:64–67. doi: 10.1016/j.meegid.2016.11.019.
  • Pignanelli S, Pulcrano G, Iula VD, Zaccherini P, Testa A, Catania MR. 2014. In vitro antimicrobial profile of Ureaplasma urealyticum from genital tract of childbearing-aged women in Northern and Southern Italy. APMIS. 122(6):552–555. doi: 10.1111/apm.12184.
  • Pónyai K, Mihalik N, Ostorházi E, Farkas B, Párducz L, Marschalkó M, Kárpáti S, Rozgonyi F. 2013. Incidence and antibiotic susceptibility of genital mycoplasmas in sexually active individuals in Hungary. Eur J Clin Microbiol Infect Dis. 32(11):1423–1426. doi: 10.1007/s10096-013-1892-y.
  • Portillo A, Ruiz-Larrea F, Zarazaga M, Alonso A, Martinez JL, Torres C. 2000. Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother. 44(4):967–971. doi: 10.1128/AAC.44.4.967-971.2000.
  • Potts JM, Sharma R, Pasqualotto F, Nelson D, Hall G, Agarwal A. 2000. Association of Ureaplasma urealyticum with abnormal reactive oxygen species levels and absence of leukocytospermia. J Urol. 163(6):1775–1778. doi: 10.1016/S0022-5347(05)67540-4.
  • Preval NMR, Spiller OB, Mondeja Rodríguez BA, Morales RS, Cintra YR, Rivera-Tapia JA. 2022. Antibiotic resistance among clinical Ureaplasma isolates from Cuban individuals between 2013 and 2018. J Med Microbiol. 71(2):001477. doi: 10.1099/jmm.0.001477.
  • Purcell RH, Taylor-Robinson D, Wong D, Chanock RM. 1966. Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol. 92(1):6–12. doi: 10.1128/jb.92.1.6-12.1966.
  • Qy W, Rh L, Lq Z, Xh S. 2016. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009–2013. Wei Mian Yu Gan Ran Za Zhi [J Microbiol Immunol Infect]. 49(3):359–362. doi: 10.1016/j.jmii.2014.06.007.
  • Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard HA, Kock MM. 2014. Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women. BMC Infect Dis. 14(1):171. doi: 10.1186/1471-2334-14-171.
  • Rice LB. 1998. Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob Agents Chemother. 42(8):1871–1877. doi: 10.1128/AAC.42.8.1871.
  • Roberts MC, Kenny GE. 1986a. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob Agents Chemother. 29(2):350–352. doi: 10.1128/AAC.29.2.350.
  • Roberts MC, Kenny GE. 1986b. TetM tetracycline-resistant determinants in Ureaplasma urealyticum. Pediatr Infect Dis. 5(6 Suppl):S338–S340. doi: 10.1097/00006454-198611010-00032.
  • Robertson J, Stemler M, Stemke G. 1984. Immunoglobulin-a protease activity of Ureaplasma-urealyticum. J Clin Microbiol. 19(2):255–258. doi: 10.1128/jcm.19.2.255-258.1984.
  • Robertson JA, Sherburne R. 1991. Hemadsorption by colonies of Ureaplasma urealyticum. Infect Immun. 59(6):2203–2206. doi: 10.1128/iai.59.6.2203-2206.1991.
  • Robertson JA, Stemke GW, Davis JW, Harasawa R, Thirkell D, Kong F, Shepard MC, Ford DK. 2002. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum. Int J Syst Evol Microbiol. 52(Pt 2):587–597. doi: 10.1099/00207713-52-2-587.
  • Robertson JA, Stemke GW. 1982. Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans. J Clin Microbiol. 15(5):873–878. doi: 10.1128/jcm.15.5.873-878.1982.
  • Robertson JA, Vekris A, Bebear C, Stemke GW. 1993. Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol. 31(4):824–830. doi: 10.1128/jcm.31.4.824-830.1993.
  • Robinson JW, Dando SJ, Nitsos I, Newnham J, Polglase GR, Kallapur SG, Pillow JJ, Kramer BW, Jobe AH, Payton D, et al. 2013. Ureaplasma parvum serovar 3 multiple banded antigen size variation after chronic intra-amniotic infection/colonization. PLOS One. 8(4):e62746. doi: 10.1371/journal.pone.0062746.
  • Rowlands RS, Kragh K, Sahu S, Maddocks SE, Bolhuis A, Spiller OB, Beeton ML. 2021. A requirement for flow to enable the development of Ureaplasma parvum biofilms in vitro. J Appl Microbiol. 131(5):2579–2585. doi: 10.1111/jam.15120.
  • Ruan X, Li M, Qin X. 2021. Diagnostic value of metagenomic next generation sequencing for Ureaplasma urealyticuminfection: a case report. Lab Med. 53(4):e74–e76. doi: 10.1093/labmed/lmab091.
  • Saada AB, Terespolski Y, Adoni A, Kahane I. 1991. Adherence of Ureaplasma urealyticum to human erythrocytes. Infect Immun. 59(1):467–469. doi: 10.1128/iai.59.1.467-469.1991.
  • Sanchez-Pescador R, Brown JT, Roberts M, Urdea MS. 1988. The nucleotide sequence of the tetracycline resistance determinant tetM from Ureaplasma urealyticum. Nucleic Acids Res. 16(3):1216–1217. doi: 10.1093/nar/16.3.1216.
  • Schneider SC, Tinguely R, Droz S, Hilty M, Donà V, Bodmer T, Endimiani A. 2015. Antibiotic susceptibility and sequence type distribution of Ureaplasma species isolated from genital samples in Switzerland. Antimicrob Agents Chemother. 59(10):6026–6031. doi: 10.1128/AAC.00895-15.
  • Senthamaraikannan P, Presicce P, Rueda CM, Maneenil G, Schmidt AF, Miller LA, Waites KB, Jobe AH, Kallapur SG, Chougnet CA. 2016. Intra-amniotic Ureaplasma parvum-induced maternal and fetal inflammation and immune responses in Rhesus Macaques. J Infect Dis. 214(10):1597–1604. doi: 10.1093/infdis/jiw408.
  • Shao L, Wu X, Gao S, Liu L, Zhang Y, Zhao H. 2021. Epidemiological investigation and antimicrobial susceptibility analysis of Ureaplasma and Mycoplasma hominis in a teaching hospital in Shenyang, China. J Infect Chemother. 27(8):1212–1216. doi: 10.1016/j.jiac.2021.03.022.
  • Shepard MC, Combs RS. 1979. Enhancement of Ureaplasma urealyticum growth on a differential agar medium (A7B) by a polyamine, putrescine. J Clin Microbiol. 10(6):931–933. doi: 10.1128/jcm.10.6.931-933.1979.
  • Shepard MC, Lunceford CD, Ford DK, Purcell RH, Taylor-Robinson D, Razin S, Black FT. 1974. Ureaplasma urealyticum gen. nov., sp. nov.: proposed nomenclature for the human T (T-strain) mycoplasmas. Int J System Bacteriol. 24(2):160–171. doi: 10.1099/00207713-24-2-160.
  • Shepard MC. 1954. The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am J Syph Gonorrhea Vener Dis. 38(2):113–124.
  • Shi J, Yang Z, Wang M, Cheng G, Li D, Wang Y, Zhou Y, Liu X, Xu C. 2007. Screening of an antigen target for immunocontraceptives from cross-reactive antigens between human sperm and Ureaplasma urealyticum. Infect Immun. 75(4):2004–2011. doi: 10.1128/IAI.01171-06.
  • Silwedel C, Haarmann A, Fehrholz M, Claus H, Speer CP, Glaser K. 2019. More than just inflammation: Ureaplasma species induce apoptosis in human brain microvascular endothelial cells. J Neuroinflammation. 16(1):38. doi: 10.1186/s12974-019-1413-8.
  • Silwedel C, Hütten MC, Speer CP, Härtel C, Haarmann A, Henrich B, Tijssen MPM, Alnakhli AA, Spiller OB, Schlegel N, et al. 2022. Ureaplasma-driven neonatal neuroinflammation: novel insights from an ovine model. Cell Mol Neurobiol. 43(2):785–795. doi: 10.1007/s10571-022-01213-8.
  • Silwedel C, Speer CP, Haarmann A, Fehrholz M, Claus H, Schlegel N, Glaser K. 2019. Ureaplasma species modulate cell adhesion molecules and growth factors in human brain microvascular endothelial cells. Cytokine. 121:154737. doi: 10.1016/j.cyto.2019.154737.
  • Skiljevic D, Mirkov D, Vukicevic J. 2016. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital. Indian J Dermatol Venereol Leprol. 82(1):37–41. doi: 10.4103/0378-6323.172903.
  • Smith DG, Russell WC, Thirkell D. 1994. Adherence of Ureaplasma urealyticum to human epithelial cells. Microbiology. 140(10):2893–2898. doi: 10.1099/00221287-140-10-2893.
  • Song J, Qiao Y, Kong Y, Ruan Z, Huang J, Song T, Zhang J, Xie X. 2015. Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species. J Med Microbiol. 64(11):1315–1320. doi: 10.1099/jmm.0.000153.
  • Song J, Wu X, Kong Y, Jin H, Yang T, Xie X, Zhang J. 2022. Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019. Front Microbiol. 13:982429. doi: 10.3389/fmicb.2022.982429.
  • Song T, Huang J, Liu Z, Zhang Y, Kong Y, Ruan Z. 2019. Antibiotic susceptibilities and genetic variations in macrolide resistance genes of Ureaplasma spp. isolated in China. New Microbiol. 42:225–227.
  • Song T, Ye A, Xie X, Huang J, Ruan Z, Kong Y, Song J, Wang Y, Chen J, Zhang J. 2014. Epidemiological investigation and antimicrobial susceptibility analysis of Ureaplasma species and Mycoplasma hominis in outpatients with genital manifestations. J Clin Pathol. 67(9):817–820. doi: 10.1136/jclinpath-2014-202248.
  • Song W-Q, Liu M-L, Li S-Y, Xiao Z-P. 2022. Recent efforts in the discovery of urease inhibitor identifications. Curr Top Med Chem. 22(2):95–107. doi: 10.2174/1568026621666211129095441.
  • Soroka AE, Akopian TA, Taraskina AE, Baĭtsur MV, Savicheva AM, Govorun VM. 2002. Allelic polymorphism of the tem(M) determinant in Mycoplasma hominis and Ureaplasma urealyticum clinical isolates resistant to tetracyclines. Genetika. 38:1463–1469.
  • Spaepen MS, Kundsin RB, Horne HW. 1976. Tetracycline-resistant T-mycoplasmas (Ureaplasma urealyticum) from patients with a history of reproductive failure. Antimicrob Agents Chemother. 9(6):1012–1018. doi: 10.1128/AAC.9.6.1012.
  • Spiller-Boulter O, Paukner S, Boostrom I, Sands K, Portal EAR, Spiller OB. 2021. Determination of in vitro antimicrobial susceptibility for Lefamulin (Pleuromutilin) for Ureaplasma Spp. and Mycoplasma hominis. Antibiotics. 10(11):1370. doi: 10.3390/antibiotics10111370.
  • Spooner R, Russell W, Thirkell D. 1992. Characterization of the immunoglobulin-a protease of Ureaplasma-urealyticum. Infect Immun. 60(6):2544–2546. doi: 10.1128/iai.60.6.2544-2546.1992.
  • Sprong KE, Mabenge M, Wright CA, Govender S. 2020. Ureaplasma species and preterm birth: current perspectives. Crit Rev Microbiol. 46(2):169–181. doi: 10.1080/1040841X.2020.1736986.
  • Stanbridge E, Hayflick L. 1967. Growth inhibition test for identification of Mycoplasma species utilizing dried antiserum-impregnated paper discs. J Bacteriol. 93(4):1392–1396. doi: 10.1128/jb.93.4.1392-1396.1967.]
  • Stimson JB, Hale J, Bowie WR, Holmes KK. 1981. Tetracycline-resistant Ureaplasma urealyticum: a cause of persistent nongonococcal urethritis. Ann Intern Med. 94(2):192–194. doi: 10.7326/0003-4819-94-2-192.
  • Sung T-J, Xiao L, Duffy L, Waites KB, Chesko KL, Viscardi RM. 2011. Frequency of Ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia. Pediatr Infect Dis J. 30(5):379–383. doi: 10.1097/INF.0b013e318202ac3a.
  • Sweeney EL, Dando SJ, Kallapur SG, Knox CL. 2017. The human Ureaplasma species as causative agents of chorioamnionitis. Clin Microbiol Rev. 30(1):349–379. doi: 10.1128/CMR.00091-16.
  • Sweeney EL, Kallapur SG, Meawad S, Gisslen T, Stephenson S-A, Jobe AH, Knox CL. 2017. Ureaplasma species multiple banded antigen (MBA) variation is associated with the severity of inflammation in vivo and in vitro in human placentae. Front Cell Infect Microbiol. 7:123. doi: 10.3389/fcimb.2017.00123.
  • Tang J, Xu Z, Zhou L, Qin H, Wang Y, Wang H. 2010. Rapid and simultaneous detection of Ureaplasma parvum and Chlamydia trachomatis antibodies based on visual protein microarray using gold nanoparticles and silver enhancement. Diagn Microbiol Infect Dis. 67(2):122–128. doi: 10.1016/j.diagmicrobio.2010.01.009.
  • Tang J, Zhou L, Liu X, Zhang C, Zhao Y, Wang Y. 2011. Novel multiplex real-time PCR system using the SNP technology for the simultaneous diagnosis of Chlamydia trachomatis, Ureaplasma parvum and Ureaplasma urealyticum and genetic typing of serovars of C. trachomatis and U. parvum in NGU. Mol Cell Probes. 25(1):55–59. doi: 10.1016/j.mcp.2010.12.001.
  • Tantengco OAG, Kechichian T, Vincent KL, Pyles RB, Medina PMB, Menon R. 2021. Inflammatory response elicited by Ureaplasma parvum colonization in human cervical epithelial, stromal, and immune cells. Reproduction. 163(1):1–10. doi: 10.1530/REP-21-0308.
  • Taylor-Robinson D, Csonka GW, Prentice MJ. 1977. Human intra-urethral inoculation of Ureaplasmas. Q J Med. 46(183):309–326.
  • Taylor-Robinson D. 2013. Urethral inflammation in male chimpanzees caused by Ureaplasmas and Chlamydia trachomatis. J Med Microbiol. 62(Pt 10):1609–1613. doi: 10.1099/jmm.0.058446-0.
  • Teng LJ, Zheng X, Glass JI, Watson HL, Tsai J, Cassell GH. 1994. Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene. J Clin Microbiol. 32(6):1464–1469. doi: 10.1128/jcm.32.6.1464-1469.1994.
  • Totten AH, Crawford CL, Dalecki AG, Xiao L, Wolschendorf F, Atkinson TP. 2019. Differential susceptibility of Mycoplasma and Ureaplasma species to compound-enhanced copper toxicity. Front Microbiol. 10:1720. doi: 10.3389/fmicb.2019.01720.
  • Triantafilou M, De Glanville B, Aboklaish AF, Spiller OB, Kotecha S, Triantafilou K. 2013. Synergic activation of toll-like receptor (TLR) 2/6 and 9 in response to Ureaplasma parvum & urealyticum in human amniotic epithelial cells. PLOS One. 8(4):e61199. doi: 10.1371/journal.pone.0061199.
  • Turunen H, Leinikki P, Jansson E. 1982. Serological characterisation of Ureaplasma urealyticum strains by enzyme-linked immunosorbent assay (ELISA). J Clin Pathol. 35(4):439–443. doi: 10.1136/jcp.35.4.439.
  • Valentine-King MA, Brown MB. 2017. Antibacterial resistance in Ureaplasma species and Mycoplasma hominis isolates from urine cultures in college-aged females. Antimicrob Agents Chemother. 61(10):e01104-17. doi: 10.1128/AAC.01104-17.
  • Valentine-King MA, Cisneros K, James MO, Huigens RW, Brown MB. 2019. Turning the tide against antibiotic resistance by evaluating novel, halogenated phenazine, quinoline, and NH125 compounds against Ureaplasma species clinical isolates and Mycoplasma type strains. Antimicrob Agents Chemother. 63(3):e02265-18. doi: 10.1128/AAC.02265-18.
  • Vargović M, Pasini M, Papić N, Andrašević S, Markotić A, Butić I, Škerk V. 2014. Antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis. Sex Transm Infect. 90(1):69–69. doi: 10.1136/sextrans-2013-051413.
  • Viscardi R, Manimtim W, He JR, Hasday JD, Sun C-CJ, Joyce B, Pierce RA. 2006. Disordered pulmonary myofibroblast distribution and elastin expression in preterm infants with Ureaplasma urealyticum pneumonitis. Pediatr Dev Pathol. 9(2):143–151. doi: 10.2350/10-05-0112.1.
  • Viscardi RM, Atamas SP, Luzina IG, Hasday JD, He J-R, Sime PJ, Coalson JJ, Yoder BA. 2006. Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res. 60(2):141–146. doi: 10.1203/01.pdr.0000228322.73777.05.
  • Viscardi RM, Manimtim WM, Sun C-CJ, Duffy L, Cassell GH. 2002. Lung pathology in premature infants with Ureaplasma urealyticum infection. Pediatr Dev Pathol. 5(2):141–150. doi: 10.1007/s10024001-0134-y.
  • Waites KB, Bade DJ, Bébéar C, Brown SD, Davidson MK, Duffy LB, Kenny G, Matlow A, Shortridge D, Talkington D, et al. 2011. Methods for antimicrobial susceptibility testing for human mycoplasmas; approved guideline, Clinical and Laboratory Standards Institute, Wayne (PA) [accessed 2023 Mar 21]. http://www.ncbi.nlm.nih.gov/books/NBK544375/.
  • Waites KB, Crabb DM, Duffy LB, Huband MD. 2015. In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas. Antimicrob Agents Chemother. 59(6):3627–3629. doi: 10.1128/AAC.04945-14.
  • Waites KB, Crabb DM, Liu Y, Duffy LB. 2016. In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human Mycoplasmas and Ureaplasmas. Antimicrob Agents Chemother. 60(12):7502–7504. doi: 10.1128/AAC.01734-16.
  • Waites KB, Crabb DM, Xiao L, Duffy LB, Leal SM. 2020. In vitro activities of eravacycline and other antimicrobial agents against human Mycoplasmas and Ureaplasmas. Antimicrob Agents Chemother. 64(8):e00698-20. doi: 10.1128/AAC.00698-20.
  • Waites KB, Crabb DM, Xiao L, Duffy LB. 2017. In vitro activities of gepotidacin (GSK2140944) and other antimicrobial agents against human Mycoplasmas and Ureaplasmas. Antimicrob Agents Chemother. 61(10):e01064-17. doi: 10.1128/AAC.01064-17.
  • Waites KB, Katz B, Schelonka RL. 2005. Mycoplasmas and Ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 18(4):757–789. doi: 10.1128/CMR.18.4.757-789.2005.
  • Wang N, Liu W, Zhou Y, Liu Y. 2019. In vitro activities of nemonoxacin and other antimicrobial agents against human Mycoplasma and Ureaplasmas isolates and their defined resistance mechanisms. Front Microbiol. 10:1890. doi: 10.3389/fmicb.2019.01890.
  • Webster AD, Taylor-Robinson D, Furr PM, Asherson GL. 1978. Mycoplasmal (ureaplasma) septic arthritis in hypogammaglobulinaemia. Br Med J. 1(6111):478–479. doi: 10.1136/bmj.1.6111.478.
  • Weisblum B. 1995. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 39(3):577–585. doi: 10.1128/AAC.39.3.577.
  • Witt A, Berger A, Gruber CJ, Petricevic L, Apfalter P, Worda C, Husslein P. 2005. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol. 193(5):1663–1669. doi: 10.1016/j.ajog.2005.03.067.
  • Xiao L, Crabb DM, Dai Y, Chen Y, Waites KB, Atkinson TP. 2014. Suppression of antimicrobial peptide expression by Ureaplasma species. Infect Immun. 82(4):1657–1665. doi: 10.1128/IAI.01231-13.
  • Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Hamilos DL, Waites KB. 2011. Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int J Antimicrob Agents. 37(4):377–379. doi: 10.1016/j.ijantimicag.2010.12.012.
  • Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Waites KB. 2012. Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States. Antimicrob Agents Chemother. 56(5):2780–2783. doi: 10.1128/AAC.06342-11.
  • Xiao L, Crabb DM, Moser SA, Duffy LB, Glass JI, Paralanov V, Waites KB. 2011. Genotypic characterization of Ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis. J Clin Microbiol. 49(9):3325–3328. doi: 10.1128/JCM.01235-11.
  • Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB. 2010. Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J Clin Microbiol. 48(8):2715–2723. doi: 10.1128/JCM.01877-09.
  • Xiao L, Paralanov V, Glass JI, Duffy LB, Robertson JA, Cassell GH, Chen Y, Waites KB. 2011. Extensive horizontal gene transfer in Ureaplasmas from humans questions the utility of serotyping for diagnostic purposes. J Clin Microbiol. 49(8):2818–2826. doi: 10.1128/JCM.00637-11.
  • Xie X, Zhang J. 2006. Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. FEMS Microbiol Lett. 259(2):181–186. doi: 10.1111/j.1574-6968.2006.00239.x.
  • Xing N, Zhao Z, Li Q, Dong Y, Li J, Zhang S. 2021. Ureaplasma parvum meningitis following atypical choroid plexus papilloma resection in an adult patient: a case report and literature review. BMC Infect Dis. 21(1):1276. doi: 10.1186/s12879-021-06975-y.
  • Xu C, Sun GF, Zhu YF, Wang YF. 1997. The correlation of Ureaplasma urealyticum infection with infertility. Andrologia. 29(4):219–226. doi: 10.1111/j.1439-0272.1997.tb00319.x.
  • Xue G, Crabb DM, Xiao L, Liu Y, Waites KB. 2018. In vitro activities of the benzoquinolizine fluoroquinolone levonadifloxacin (WCK 771) and other antimicrobial agents against Mycoplasmas and Ureaplasmas in humans, including isolates with defined resistance mechanisms. Antimicrob Agents Chemother. 62(11):e01348-18. doi: 10.1128/AAC.01348-18.
  • Yang T, Li X, Zhang Y, Kong Y, Yu H, Ruan Z, Xie X, Zhang J. 2020. Comparative genomics of three clinical Ureaplasma species: analysis of their core genomes and multiple-banded antigen locus. Future Microbiol. 15(1):49–61. doi: 10.2217/fmb-2019-0090.
  • Yang T, Pan L, Wu N, Wang L, Liu Z, Kong Y, Ruan Z, Xie X, Zhang J. 2020. Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying quinolone resistance. Antimicrob Agents Chemother. 64(6):e02560–19. doi: 10.1128/AAC.02560-19.
  • Yazdani M, Thupili CR. 2012. Cystitis, pyelonephritis and perinephric abscess due to Ureaplasma urealyticum. J Urol. 188(6):2373–2374. doi: 10.1016/j.juro.2012.09.071.
  • Ye G, Jiang Z, Wang M, Huang J, Jin G, Lu S. 2014. The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens. Cell Biochem Biophys. 68(1):207–210. doi: 10.1007/s12013-013-9691-8.
  • Ye G-Y, Wang K-Y, Gui Q, Wang M. 2018. Ureaplasma urealyticum-derived lipid-associated membrane proteins introduce IL-6, IL-8, and TNF-α cytokines into human amniotic epithelial cells via Toll-like receptor 2. J Zhejiang Univ Sci B. 19(8):654–661. doi: 10.1631/jzus.B1800005.
  • Yoder BA, Coalson JJ, Winter VT, Siler-Khodr T, Duffy LB, Cassell GH. 2003. Effects of antenatal colonization with Ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res. 54(6):797–807. doi: 10.1203/01.PDR.0000091284.84322.16.
  • Yoshida T, Deguchi T, Meda S-I, Kubota Y, Tamaki M, Yokoi S, Yasuda M, Ishiko H. 2007. Quantitative detection of Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in urine specimens from men with and without urethritis by real-time polymerase chain reaction. Sex Transm Dis. 34(6):416–419. doi: 10.1097/01.olq.0000243621.89212.40.
  • Zeng X-Y, Xin N, Tong X-N, Wang J-Y, Liu Z-W. 2016. Prevalence and antibiotic susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Xi’an, China. Eur J Clin Microbiol Infect Dis. 35(12):1941–1947. doi: 10.1007/s10096-016-2745-2.
  • Zhang J, Kong Y, Feng Y, Huang J, Song T, Ruan Z, Song J, Jiang Y, Yu Y, Xie X. 2014. Development of a multilocus sequence typing scheme for Ureaplasma. Eur J Clin Microbiol Infect Dis. 33(4):537–544. doi: 10.1007/s10096-013-1981-y.
  • Zhang J, Kong Y, Ruan Z, Huang J, Song T, Song J, Jiang Y, Yu Y, Xie X. 2014. Correlation between Ureaplasma subgroup 2 and genitourinary tract disease outcomes revealed by an expanded multilocus sequence typing (eMLST) scheme. PLOS One. 9(8):e104347. doi: 10.1371/journal.pone.0104347.
  • Zhang N, Wang R, Li X, Liu X, Tang Z, Liu Y. 2014. Are Ureaplasma spp. a cause of nongonococcal urethritis? A systematic review and meta-analysis. PLOS One. 9(12):e113771. doi: 10.1371/journal.pone.0113771.
  • Zhang Q, Xiao Y, Zhuang W, Cheng B, Zheng L, Cai Y, Zhou H, Wang Q. 2014. Effects of biovar I and biovar II of Ureaplasma urealyticum on sperm parameters, lipid peroxidation, and deoxyribonucleic acid damage in male infertility. Urology. 84(1):87–92. doi: 10.1016/j.urology.2014.04.014.
  • Zhang T, Li H, Hou S, Yu H, Yue W. 2021. Case report of Ureaplasma urealyticum meningitis in a patient with thymoma and hypogammaglobulinaemia. BMC Infect Dis. 21(1):1142. doi: 10.1186/s12879-021-06831-z.
  • Zhang W, Li L, Zhang X, Fang H, Chen H, Rong C. 2021. Infection prevalence and antibiotic resistance levels in Ureaplasma urealyticum and Mycoplasma hominis in gynecological outpatients of a tertiary hospital in China from 2015 to 2018. Can J Infect Dis Med Microbiol. 2021:8842267–8842266. doi: 10.1155/2021/8842267.
  • Zhang Y, Hua C, Li S-L. 2018. The relationship between the biovars and the antimicrobial resistance of Ureaplasma urealyticum in female patients with urogenital infections. Clin Lab Anal. 32(1):e22211. doi: 10.1002/jcla.22211.
  • Zhao L, Liu A, Li R, Zhao S. 2020. Antimicrobial resistance, genetic characterization, and molecular epidemiology of Ureaplasma species in males with infertility. Eur J Clin Microbiol Infect Dis. 39(11):2177–2183. doi: 10.1007/s10096-020-03969-7.
  • Zheng X, Teng LJ, Watson HL, Glass JI, Blanchard A, Cassell GH. 1995. Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation. Infect Immun. 63(3):891–898. doi: 10.1128/iai.63.3.891-898.1995.
  • Zhou Y-H, Ma H-X, Yang Y, Gu W-M. 2018. Prevalence and antimicrobial resistance of Ureaplasma spp. and Mycoplasma hominis isolated from semen samples of infertile men in Shanghai, China from 2011 to 2016. Eur J Clin Microbiol Infect Dis. 37(4):729–734. doi: 10.1007/s10096-017-3167-5.
  • Zhu G-X, Lu C, Chen C-J, Feng P-Y, Ma H, Lu R-B, Yuan Y-L. 2011. Pathogenicity of Ureaplasma urealyticum and Ureaplasma parvum in the lower genital tract of female BALB/c mice. Can J Microbiol. 57(12):987–992. doi: 10.1139/w11-098.
  • Zimmerman C-UR, Herrmann R, Rosengarten R. 2015. XerC-mediated DNA inversion at the inverted repeats of the UU172-phase-variable element of Ureaplasma parvum serovar 3. Microbiol Res. 170:263–269. doi: 10.1016/j.micres.2014.09.002.
  • Zimmerman C-UR, Rosengarten R, Spergser J. 2011. Ureaplasma antigenic variation beyond MBA phase variation: DNA inversions generating chimeric structures and switching in expression of the MBA N-terminal paralogue UU172. Mol Microbiol. 79(3):663–676. doi: 10.1111/j.1365-2958.2010.07474.x.
  • Zimmerman C-UR, Stiedl T, Rosengarten R, Spergser J. 2009. Alternate phase variation in expression of two major surface membrane proteins (MBA and UU376) of Ureaplasma parvum serovar 3. FEMS Microbiol Lett. 292(2):187–193. doi: 10.1111/j.1574-6968.2009.01505.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.